Document:

Agreement
by and between Zander Therapeutics, Inc. (“Zander”), KCL Therapeutics, Inc. (“KCL”) and Regen BioPharma,
Inc. (“Regen”) as of December 16, 2019. For purposes of this Agreement Regen and KCL may be also referred to singularly
or collectively as “Licensor”. For purposes of this Agreement Regen, KCL and Zander may be collectively referred to
as the “Parties” or individually as a “Party”. The effective date of this Agreement is December 16, 2019.

WHEREAS:

On
June 23, 2015 Zander and Regen have entered into an agreement, as amended(“License Agreement”) whereby Regen granted
to Zander an exclusive worldwide right and license for the development and commercialization of certain intellectual property
controlled by Regen for non-human veterinary therapeutic use for a term of fifteen years.

On
December 17, 2018 Regen, KCL and Zander entered into a License Assignment And Consent agreement whereby Regen transferred and
assigned to KCL all rights, duties, and obligations of Regen under the License Agreement and KCL agreed to assume such duties
and obligations thereunder and be bound to the terms of the License Agreement with respect thereto. KCL is a wholly owned subsidiary
of Regen and Regen acknowledges that Regen will benefit from any payments made to KCL.

Pursuant
to the License Agreement, Zander is obligated to pay Licensor an annual non-refundable payment of one hundred thousand US dollars
($100,000) on each anniversary of the effective date of the License Agreement and Zander is obligated to pay Licensor minimum
annual royalties of ten thousand US dollars ($10,000) payable per year on each anniversary of the effective date of the License
Agreement. Collectively, minimum annual payments due by Zander to the Licensor pursuant to the License Agreement equal $110,000
USD per annum (“License Agreement Payments”).

As
of the date of this Agreement, Zander has failed to pay $42,000 USD of the License Agreement Payments due and payable by June
2019.

On
September 30, 2018 Regen issued a convertible promissory note in the principal amount of $350,000 USD (“Convertible Note”)
to Zander for cash payments paid by Zander to Regen equaling $350,000 USD. A onetime interest charge of 10% of the principal amount
shall be applied to the principal amount of the Convertible Note (“Convertible Note One Time Charge”). On June 27,
2019 Zander converted $340,000 of the principal amount of the Convertible Note into 194,285,714 shares of the Series A Preferred
stock of Regen (“Conversion Shares”).

As
of the date of this Agreement, exclusive of amounts due to Zander pursuant to the Convertible Note, Zander is owed by Regen the
principal amount of $75,900 USD resulting from Notes Payable issued by Regen to Zander (“Regen Notes”) and Zander
is owed $4,328 USD resulting from interest accrued but unpaid on the Regen Notes (“Accrued Interest”).

THEREFORE,
IT IS AGREED AS FOLLOWS:

		1.	On
                                         or before December 20, 2019 Zander shall return the Conversion Shares to Regen for cancellation
                                         (“Rescission”) and upon Rescission the parties agree that the original principal
                                         balance of the Convertible Note of $350,000 USD shall become a liability of Regen to
                                         Zander. Rescission shall be deemed to have occurred upon the date of submission to Regen
                                         by Zander of the Conversion Shares along with written instructions by Zander directing
                                         Regen and/or Regen’s Transfer Agent to cancel the Conversion Shares (“Return
                                         Date”). Subsequent to the Rescission the principal Balance of $350,000 USD shall
                                         no longer be convertible into equity securities of Regen and shall be applied to Annual
                                         License Agreement Payments in accordance with Section 3 of this Agreement.

		2.	As
                                         of a result of the Rescission, as of the Return Date Regen shall owe Zander the aggregate
                                         amount of $465,228 (“Aggregate Debt”) consisting of the following:

 

	Principal Balance of Convertible Note	 	 	 $           350,000  USD	 
	Convertible Note One Time Charge	 	 	 $             35,000  USD	 
	Regen Notes	 	 	 $             75,900 USD	 
	Accrued Interest	 	 	$                 4,328 USD	 
	 Total	 	 	 $           465,228  USD	 

 

		3.	The
                                         Aggregate Debt shall be applied to Annual License Agreement Payments as follows :

	 	2019	 	 	 	$42,000 USD	 
	 	2020	 	 	 	$110,000 USD	 
	 	2021	 	 	 	$110,000 USD	 
	 	2022	 	 	 	$110,000 USD	 
	 	2023	 	 	 	$93,228 USD	 
	 	Total	 	 	 	$465,228 USD	 

 

Application
of portions of the Aggregate Debt towards the satisfaction of Annual License Agreement Payments that have not yet come due shall
be considered by the Parties to be prepayment of such Annual License Agreement Payments and shall bear no interest from the effective
date of this Agreement except in accordance with Section 5 of this Agreement. 

		4.	In
                                         the event that for any reason other than as a result of deliberate action by either of:

		(a)	Regen

		(b)	a
                                         subsidiary ( wholly or partially owned) of Regen

		(c)	an
                                         agent of Regen

		(d)	KCL

		(e)	a
                                         subsidiary ( wholly or partially owned) of KCL

		(f)	an
                                         agent of KCL

Zander’s
rights or privileges pursuant to the License Agreement are diminished or impaired then, upon written demand by Zander, Regen and
KCL shall become jointly and severally liable to Zander for an amount in cash equal to that portion of the Aggregate Debt which
constitutes prepayments of License Agreement Payments which have not yet become due. Payment pursuant to this Section 4 shall
be made within ten days of written demand by Zander.

		5.	In
                                         the event that as a result of deliberate action by either of:

		(a)	Regen

		(b)	a
                                         subsidiary ( wholly or partially owned) of Regen

		(c)	an
                                         agent of Regen

		(d)	KCL

		(e)	a
                                         subsidiary ( wholly or partially owned) of KCL

		(f)	an
                                         agent of KCL

Zander’s
rights or privileges pursuant to the License Agreement are diminished or impaired then, upon written demand by Zander, Regen and
KCL shall become jointly and severally liable to Zander for an amount in cash equal to the sum of:

		(a)	the
                                         total Aggregate Debt of $465,228USD 

		(b)	simple
                                         interest on the Aggregate Debt of 10% per annum to be calculated from the effective date
                                         of this Agreement to the date of actual payment pursuant to this Section 5

		(c)	a
                                         penalty payment of $ $150,000 USD.

Payment
pursuant to this Section 5 shall be made within ten days of written demand by Zander.

		6.	If
                                         any provision of this Agreement or the application thereof to any person or circumstance
                                         is determined by a court of competent jurisdiction to be invalid, void or unenforceable,
                                         the remaining provisions hereof, or the application of such provision to persons or circumstances
                                         other than those as to which it has been held invalid or unenforceable, will remain in
                                         full force and effect and shall in no way be affected, impaired or invalidated thereby,
                                         so long as the economic or legal substance of the transactions contemplated hereby is
                                         not affected in any manner materially adverse to any party. Upon such determination,
                                         the Parties hereto shall negotiate in good faith in an effort to agree upon a suitable
                                         and equitable substitute provision to affect the original intent of the Parties.

 

		7.	Zander
                                         represents to Regen and KCL that:

 

a)
Zander is a corporation duly organized, validly existing and in good standing under the laws of the state of its incorporation
and has the requisite corporate power and authority to enter into and perform its obligations under this Agreement without the
consent, approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not
been obtained.

(b)
The execution, delivery and performance of this Agreement by Zander does not and shall not constitute Zander’s breach of
any statute or regulation or ordinance of any governmental authority, and shall not conflict with or result in a breach of or
default under any of the terms, conditions, or provisions of any order, writ, injunction, decree, contract, agreement, or instrument
to which Zander is a party, or by which Zander is or may be bound. 

		8.	Regen
                                         and KCL jointly and severally represent to Zander:

 

a)
Both of Regen and KCL are corporations duly organized, validly existing and in good standing under the laws of the state of their
respective incorporation and each has the requisite corporate power and authority to enter into and perform its obligations under
this Agreement without the consent, approval or authorization of, or obligation to notify, any person, entity or governmental
agency which consent has not been obtained.

(b)
The execution, delivery and performance of this Agreement by either Regen or KCL Zander does not and shall not constitute either
Regen or KCL’s breach of any statute or regulation or ordinance of any governmental authority, and shall not conflict with
or result in a breach of or default under any of the terms, conditions, or provisions of any order, writ, injunction, decree,
contract, agreement, or instrument to which either Regen or KCL is a party, or by which either Regen or KCL is or may be bound.

		9.	This
                                         Agreement constitutes a final written expression of all the terms of the Agreement between
                                         the Parties hereto regarding the subject matter hereof, are a complete and exclusive
                                         statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings,
                                         and representations between the Parties hereto. This Agreement may be altered or modified
                                         only in writing signed by the Parties hereto.

 

		10.	All
                                         questions concerning the construction, validity, enforcement and interpretation of this
                                         Agreement shall be governed by and construed and enforced in accordance with the internal
                                         laws of the State of California, without regard to the principles of conflicts of law
                                         thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state
                                         and federal courts sitting in California for the adjudication of any dispute hereunder
                                         or in connection herewith or with any transaction contemplated hereby or discussed herein
                                         and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
                                         any claim that it is not personally subject to the jurisdiction of any such court, that
                                         such suit, action or proceeding is improper or inconvenient venue for such proceeding.
                                         If either party shall commence an action or proceeding to enforce any provisions of this
                                         Agreement, then the prevailing party in such action or proceeding shall be reimbursed
                                         by the other party for its attorneys’ fees and other costs and expenses incurred
                                         with the investigation, preparation and prosecution of such action or proceeding.

 

IN
WITNESS WHEREOF, the parties have hereunto executed this Agreement on the 16th day of December, 2019.

	Regen
    BioPharma, Inc.:	Zander
    Therapeutics, Inc.
	Signature:

        By:
        David R. Koos
	Signature:

        By:
        David R. Koos

	Its:  Chairman
    & CEO	Its:  Chairman
    & CEO
	Signature
    and Date: December 16, 2019	Signature
    and Date: December 16, 2019
	KCL
    Therapeutics, Inc.	 
	Signature:

        By:
        David R. Koos
	 
	Its:  Chairman
    & CEO	 
	Signature
    and Date: December 16, 2019Exhibit 10.1

 

THE EXCHANGE CONTEMPLATED HEREIN IS
INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED.

 

EXCHANGE AGREEMENT

 

This Exchange Agreement
(this “Agreement”) is entered into as of December 18, 2019 by and between Chicago Venture Partners, L.P., a
Utah limited partnership (“Lender”), and Inpixon, a Nevada corporation (“Borrower” or the
“Company”). Capitalized terms used in this Agreement without definition shall have the meanings given to them
in the Original Note (defined below).

 

A. Borrower previously
sold and issued to Lender that certain Promissory Note dated May 3, 2019 (the “Original Note”), in the original
principal amount of $3,770,000.00 pursuant to that certain Note Purchase Agreement dated May 3, 2019 by and between Lender and
Borrower, as amended (the “Purchase Agreement,” and together with the Original Note and all other documents
entered into in conjunction therewith, the “Transaction Documents”).

 

B. Subject to the terms
of this Agreement, Borrower and Lender desire to partition a new Promissory Note in the form of the Original Note (the “Partitioned
Note”) in the original principal amount of $240,000.00 (“Exchange Amount”) from the Original Note
and then cause the outstanding balance of the Original Note to be reduced by an amount equal to the Exchange Amount, which represents
the total outstanding balance of the Partitioned Note.

 

C. Borrower and Lender
further desire to exchange (such exchange is referred to as the “Note Exchange”) the Partitioned Note for the
delivery of 5,000,000 shares of the Company’s Common Stock, par value $0.001 (the “Common Stock”, and
such 5,000,000 shares of Common Stock, the “Exchange Shares”), at an effective price per Exchange Share equal
to $0.048, according to the terms and conditions of this Agreement.

 

D. The Note Exchange
will consist of Lender surrendering the Partitioned Note in exchange for the Exchange Shares, which will be issued free of any
restrictive securities legend. Other than the surrender of the Partitioned Note, no consideration of any kind whatsoever shall
be given by Lender to Borrower in connection with this Agreement.

 

E. Lender and Borrower
have agreed to exchange the Partitioned Note for the Exchange Shares on the terms and conditions set forth herein.

 

NOW, THEREFORE, for
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1. Recitals and
Definitions. Each of the parties hereto acknowledges and agrees that the recitals set forth above in this Agreement are true
and accurate, are contractual in nature, and are hereby incorporated into and made a part of this Agreement.

 

     

     

    

 

2. Partition.
Effective as of the date hereof, Borrower and Lender agree that the Partitioned Note is hereby partitioned from the Original Note.
Following such partition of the Original Note, Borrower and Lender agree that the Original Note shall remain in full force and
effect, provided that the outstanding balance of the Original Note shall be reduced by an amount equal to the Exchange Amount.

 

3. Issuance of Exchange
Shares. Pursuant to the terms and conditions of this Agreement, the Exchange Shares shall be delivered to Lender on or before
December 20, 2019 and the Note Exchange shall occur with Lender surrendering the Partitioned Note to Borrower on the Free Trading
Date (as defined below). On the Free Trading Date, the Partitioned Note shall be cancelled and all obligations of Borrower under
the Partitioned Note shall be deemed fulfilled. All Exchange Shares delivered hereunder shall be delivered via DWAC to Lender’s
designated brokerage account. Borrower agrees to provide all necessary cooperation or assistance that may be required to cause
all Exchange Shares delivered hereunder to become Free Trading (the first date such occurs, the “Free Trading Date”).
For purposes hereof, the term “Free Trading” means that (a) the Exchange Shares have been cleared and approved
for public resale by the compliance departments of Lender’s brokerage firm and the clearing firm servicing such brokerage,
and (b) such shares are held in the name of the clearing firm servicing Lender’s brokerage firm and have been deposited into
such clearing firm’s account for the benefit of Lender.

 

4. Closing.
The closing of the transactions contemplated hereby (the “Closing”) along with the delivery of the Exchange
Shares to Lender shall occur on the date that is mutually agreed to by Borrower and Lender by means of the exchange by email of
..pdf documents, but shall be deemed to have occurred at the offices of Hansen Black Anderson Ashcraft PLLC in Lehi, Utah.

 

5. Holding Period,
Tacking and Legal Opinion. Borrower represents, warrants and agrees that for the purposes of Rule 144 (“Rule 144”)
of the Securities Act of 1933, as amended (the “Securities Act”), the holding period of the Partitioned Note
and the Exchange Shares will include Lender’s holding period of the Original Note from May 3, 2019. Borrower agrees not to
take a position contrary to this Section 5 in any document, statement, setting, or situation. Borrower agrees to take all action
necessary to issue the Exchange Shares without restriction, and not containing any restrictive legend without the need for any
action by Lender; provided that the applicable holding period has been met. In furtherance thereof, at the Closing, counsel to
Lender may, in its sole discretion, provide an opinion that: (a) the Exchange Shares may be resold pursuant to Rule 144 without
volume or manner-of-sale restrictions; and (b) the transactions contemplated hereby and all other documents associated with this
transaction comport with the requirements of Section 3(a)(9) of the Securities Act. Borrower represents that it is not subject
to Rule 144(i). The Exchange Shares are being issued in substitution of and exchange for and not in satisfaction of the Partitioned
Note. The Exchange Shares shall not constitute a novation or satisfaction and accord of the Partitioned Note. Borrower acknowledges
and understands that the representations and agreements of Borrower in this Section 5 are a material inducement to Lender’s
decision to consummate the transactions contemplated herein.

 

    2

     

    

 

6. Representations,
Warranties and Agreements.

 

(a) Borrower Representations,
Warranties and Agreement. In order to induce Lender to enter into this Agreement, Borrower, for itself, and for its affiliates,
successors and assigns, hereby acknowledges, represents, warrants and agrees as follows: (a) Borrower has full power and authority
to enter into this Agreement and to incur and perform all obligations and covenants contained herein, all of which have been duly
authorized by all proper and necessary action, (b) no consent, approval, filing or registration with or notice to any governmental
authority is required as a condition to the validity of this Agreement or the performance of any of the obligations of Borrower
hereunder, (c) no Event of Default has occurred under the Original Note and any Events of Default that may have occurred thereunder
have not been, and are not hereby, waived by Lender, (d) except as specifically set forth herein, nothing herein shall in any manner
release, lessen, modify or otherwise affect Borrower’s obligations under the Original Note, (e) the issuance of the Exchange
Shares is duly authorized by all necessary corporate action and the Exchange Shares, when issued in accordance with the terms hereof,
will be validly issued, fully paid and non-assessable, free and clear of all taxes, liens, claims, pledges, mortgages, restrictions,
obligations, security interests and encumbrances of any kind, nature and description, (f) Borrower has not received any consideration
in any form whatsoever for issuing the Exchange Shares, other than the surrender of the Partitioned Note, and (g) Borrower has
taken no action which would give rise to any claim by any person for a brokerage commission, placement agent or finder’s
fee or other similar payment by Borrower related to this Agreement.

 

(b) Lender Representations
Warranties and Agreement. In order to induce the Company to enter into this Agreement, Lender for itself, and for its affiliates,
successors and assigns, hereby acknowledges, represents, warrants and agrees as follows: (a) Lender has full power and authority
to enter into this Agreement and to incur and perform all obligations and covenants contained herein, all of which have been duly
authorized by all proper and necessary action, (b) no consent, approval, filing or registration with or notice to any governmental
authority is required as a condition to the validity of this Agreement or the performance of any of the obligations of Lender hereunder,
(c) the Lender understands that the Exchange Shares are being offered and exchanged in reliance on specific exemptions from the
registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth
and accuracy of, and the Lender’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of the Lender set forth herein and in the Exchange Documents in order to determine the availability of such exemptions and the
eligibility of the Lender to acquire the Exchange Shares, (d) the Lender understands that no United States federal or state agency
or any other government or governmental agency has passed on or made any recommendation or endorsement of the the Partitioned Note
or the Exchange Shares or the fairness or suitability of the investment in the Partitioned Note or the Exchange Shares nor have
such authorities passed upon or endorsed the merits of the offering of the Partitioned Note or the Exchange Shares, (e) the Lender
is acquiring the Partitioned Note in the ordinary course of its business, the Lender has such knowledge, sophistication, and experience
in business and financial matters so as to be capable of evaluation of the merits and risks of the prospective investment in the
Partitioned Note and Exchange Shares and has so evaluated the merits and risk of such investment and the Lender is an “accredited
investor” as defined in Regulation D under the Securities Act, (f) the Lender owns the Original Note free and clear of any
liens, (g) the Lender shall not sell, purchase, trade or otherwise dispose of or acquire any shares of Common Stock or other securities
of the Company until a Current Report on Form 8-K disclosing the transactions contemplated hereunder is filed with the U.S. Securities
and Exchange Commission, which shall be filed no later than 5:30pm EST as of the date hereof, (h) the issuance of the Exchange
Shares shall not result in the Lender beneficially owning a number of shares of Common Stock, when aggregated with any other shares
of Common Stock beneficially owned at such time, that would result in the Lender beneficially owning (as determined in accordance
with Section 13(d) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder) more than 4.99% of
all of the issued and outstanding shares of Common Stock and (i) the Lender understands that this Agreement does not constitute
an admission of liability by any party, including any admission of default under the Transaction
Documents.

 

    3

     

    

 

7. Arbitration.
By its execution of this Agreement, each party agrees to be bound by the Arbitration Provisions (as defined in the Purchase Agreement)
set forth as an exhibit to the Purchase Agreement and the parties agree to submit all Claims (as defined in the Purchase Agreement)
arising under this Agreement or any Transaction Document or other agreement between the parties and their affiliates to binding
arbitration pursuant to the Arbitration Provisions.

 

8. Governing Law;
Venue. This Agreement shall be construed and enforced in accordance with, and all questions concerning the construction, validity,
interpretation and performance of this Agreement shall be governed by, the internal laws of the State of Utah, without giving effect
to any choice of law or conflict of law provision or rule (whether of the State of Utah or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of Utah. The provisions set forth in the Purchase Agreement
to determine the proper venue for any disputes are incorporated herein by this reference. BORROWER
HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

9. Counterparts.
This Agreement may be executed in any number of counterparts with the same effect as if all signing parties had signed the same
document. All counterparts shall be construed together and constitute the same instrument. The exchange of copies of this Agreement
and of signature pages by facsimile transmission or other electronic transmission (including email) shall constitute effective
execution and delivery of this Agreement as to the parties and may be used in lieu of the original Agreement for all purposes.
Signatures of the parties transmitted by facsimile transmission or other electronic transmission (including email) shall be deemed
to be their original signatures for all purposes.

 

10. Attorneys’
Fees. In the event of any arbitration or action at law or in equity to enforce or interpret the terms of this Agreement, the
parties agree that the party who is awarded the most money shall be deemed the prevailing party for all purposes and shall therefore
be entitled to an additional award of the full amount of the attorneys’ fees and expenses  paid by such prevailing party
in connection with the arbitration, litigation and/or dispute without reduction or apportionment based upon the individual claims
or defenses  giving rise to the fees and expenses.  Nothing herein shall restrict or impair an arbitrator’s or
a court’s power to award fees and expenses for frivolous or bad faith pleading.

 

    4

     

    

 

11. No Reliance.
Borrower acknowledges and agrees that neither Lender nor any of its officers, directors, members, managers, equity holders, representatives
or agents has made any representations or warranties to Borrower or any of its agents, representatives, officers, directors, or
employees except as expressly set forth in this Agreement and the Transaction Documents and, in making its decision to enter into
the transactions contemplated by this Agreement, Borrower is not relying on any representation, warranty, covenant or promise of
Lender or its officers, directors, members, managers, equity holders, agents or representatives other than as set forth in this
Agreement.

 

12. Severability.
If any part of this Agreement is construed to be in violation of any law, such part shall be modified to achieve the objective
of the parties to the fullest extent permitted and the balance of this Agreement shall remain in full force and effect.

 

13. Entire Agreement.
This Agreement, together with the Transaction Documents, and all other documents referred to herein, supersedes all other prior
oral or written agreements between Borrower, Lender, its affiliates and persons acting on its behalf with respect to the matters
discussed herein, and this Agreement and the instruments referenced herein contain the entire understanding of the parties with
respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither Lender nor Borrower
makes any representation, warranty, covenant or undertaking with respect to such matters.

 

14. Amendments.
This Agreement may be amended, modified, or supplemented only by written agreement of the parties. No provision of this Agreement
may be waived except in writing signed by the party against whom such waiver is sought to be enforced.

 

15. Successors and
Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns.
This Agreement or any of the severable rights and obligations inuring to the benefit of or to be performed by Lender hereunder
may be assigned by Lender to a third party, including its financing sources, in whole or in part. Borrower may not assign this
Agreement or any of its obligations herein without the prior written consent of Lender.

 

16. Continuing Enforceability;
Conflict Between Documents. Except as otherwise modified by this Agreement, the Original Note, the Partitioned Note and each
of the other Transaction Documents shall remain in full force and effect, enforceable in accordance with all of its original terms
and provisions. This Agreement shall not be effective or binding unless and until it is fully executed and delivered by Lender
and Borrower. If there is any conflict between the terms of this Agreement and the Partitioned Note, on the one hand, and the Original
Note or any other Transaction Document, on the other hand, the terms of this Agreement and the Partitioned Noted shall prevail.

 

17. Time of Essence.
Time is of the essence with respect to each and every provision of this Agreement.

 

18. Notices.
Unless otherwise specifically provided for herein, all notices, demands or requests required or permitted under this Agreement
to be given to Borrower or Lender shall be given as set forth in the “Notices” section of the Purchase Agreement.

 

    5

     

    

 

19. Further Assurances.
Each party shall do and perform or cause to be done and performed, all such further acts and things, and shall execute and deliver
all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry
out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

    6

     

    

 

IN WITNESS WHEREOF,
the undersigned have executed this Agreement as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	INPIXON
	 	 	 
	 	By:	/s/ Nadir Ali
	 	Name: 	Nadir Ali
	 	Title:	CEO

 

	 	LENDER:
	 	 
	 	CHICAGO VENTURE PARTNERS, L.P.
	 	 	 	 
	 	By:	Chicago Venture Management, L.L.C., its
	 	 	General Partner
	 	 	 	 
	 	 	By:	CVM, Inc., its Manager
	 	 	 	 
	 	 	By: 	/s/ John M. Fife
	 	 	 	John M. Fife, President

 

[Signature
Page to Exchange Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]